Vorinostat and Rituximab in Treating Patients With Indolent Non-Hodgkin Lymphoma
Clinical trial NCT00720876 · COMPLETED
Trial details
- NCT number
- NCT00720876
- Sponsor
- City of Hope Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-23
- Primary completion
- 2017-06-08
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.